Section divider

Since the 1980s, we’ve supported quality health care for Congolese families.

  • Jhpiego collaborated with the National Program for Reproductive Health to train 34 provincial trainers and health care workers, culminating in the availability of family planning (FP) services, including postpartum FP, at 40 health centers and eight hospitals in Tshopo and Bas-Uele provinces. Provincial trainers ensured training of 96 providers and 120 community health workers. Prior to this intervention, family planning services were virtually nonexistent in these provinces.
  • Due to Jhpiego’s capacity-building efforts, the national associations of midwives, nurses, pediatricians and obstetricians now have in-house capability to provide and train others to provide essential services in postpartum family planning and maternal and newborn health. There is also a model training center in Kinshasa that provides competency-based in-service and pre-service training to providers and medical students.
  • Jhpiego introduced a new capacity-building approach with low-dose, high-frequency, on-site training at 16 facilities, resulting in improved management of normal and complicated deliveries and uptake of immediate postpartum FP. Among improvements in service delivery, an average of 40% of postpartum women and 50% of postabortion women accept an FP method prior to leaving the facility. Timely and correct management of pre-eclampsia and eclampsia improved from 30% to 100%, and successful resuscitation of newborns improved from 60% to 95%.
  • Through the Jhpiego-led TIPTOP project, community implementation of intermittent preventive treatment of malaria in pregnancy (IPTp) is helping to increase IPTp coverage among pregnant women receiving antenatal care (from 26% to 85%  for third dose of IPTp), thereby giving these women more opportunities to receive malaria protection and comprehensive care in pregnancy. Early initiation of antenatal care also increased in project areas from 46% to 57%.

Our Work in DRC

Jhpiego is leading this five-year project, funded by the U.S. Centers for Disease Control and Prevention, to support Global Health Security in DRC in partnership with the Ministry of Health, other governmental institutions and Global Health Security implementing partners. This project is supporting the establishment of a public health emergency management program, including permanent staff, to establish national policies, regulatory/legislative frameworks and guidance documents. It is also assisting in the development and establishment of a National Public Health Institute that will integrate core public health functions including surveillance, public health emergency management, workforce development and the national laboratory system. In addition, the project supports national efforts to prevent, detect and respond to outbreaks of COVID-19 and Ebola. Jhpiego is leading the project consortium with partners the JHU Applied Physics Laboratory, the Kinshasa School of Public Health and DRC’s National Biomedical Research Institute.

With funding from the Bill & Melinda Gates Foundation, Jhpiego is implementing a three-year project to increase the coverage of facility-based, high-impact post-pregnancy interventions. These interventions include care of the mother and newborn on the day of birth through the first week postpartum, as well postabortion services. At 16 health care facilities in Kinshasa, Jhpiego is using an innovative low-dose, high-frequency training approach to build the technical competency of the health care providers to deliver a comprehensive package of key maternal and newborn health interventions. In addition, Jhpiego is using a quality improvement approach to build the capacity for structured problem-solving at the facility and zonal levels to sustain integrated day-of-birth and post-pregnancy interventions in project sites and beyond.

Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here: www.tiptopmalaria.org

This three-year project, funded by the Bill & Melinda Gates Foundation, seeks to uphold the quality of contraceptive implant services by working at the global and country levels. Globally, Jhpiego serves in a technical advisory role for the Implant Access Program’s Operations Group—a working group comprised of donor representatives that supports quality implant programs—to monitor, identify and collaboratively respond to priority issues. Jhpiego also provides short-term technical assistance to ensure that several countries with high implant use, including the Democratic Republic of Congo, incorporate a quality implant removal component into overall implant strategy and implementation.

This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including the Democratic Republic of Congo.